- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Laryngeal inflammatory myofibroblastic tumor (IMT): a case report and review of the literature
© The Author(s). 2016
Received: 4 December 2015
Accepted: 2 June 2016
Published: 23 June 2016
This case report is interesting as cases of children with laryngeal inflammatory myofibroblastic tumor are not common and previously had been presented as isolated case reports. This is the first case report in Asia describing a laryngeal inflammatory myofibroblastic tumor and its removal using an endoscopic approach.
Our patient is a 12-year-old Malay girl from Singapore who presented with hoarseness without respiratory distress. The initial impression was that of a granuloma or a papilloma. We did a biopsy, which confirmed the histology to be inflammatory myofibroblastic tumor, and a magnetic resonance imaging scan showed a contrast-enhanced lesion. The lesion was excised completely using an endoscopic approach. The child was discharged well on the first postoperative day and she has been on follow-up for a year in the clinic.
This report highlights the importance of understanding the differential diagnosis for a child with hoarseness. It is not uncommon for a pediatrician, a general practitioner, and a pediatric otolaryngologist to see a child presenting with hoarseness. In most cases, the diagnosis made would be screamer’s nodules, which is commonly seen in children. In a small group, recurrent respiratory papillomatosis form the diagnosis. Over the past few years, the cases of recurrent respiratory papillomatosis have decreased significantly. Laryngeal tumors are not common in children. However, we must maintain a high index of suspicion when we have a child with hoarseness who does not improve with speech therapy and watchful waiting. In such situations, a stroboscope is usually necessary to diagnose the voice problems and to rule out pathological conditions such as laryngeal tumors. If left untreated, the lesion can grow with time and result in a life-threatening airway condition. We also demonstrate our endoscopic technique in this report, and it has proven to be safe with no increased recurrence and much lower morbidity.
Inflammatory myofibroblastic tumors (IMT) are rare tumors that have a wide spectrum of histological features ranging from plasma cell-rich lesions to myofibroblast-predominant lesions. These lesions are frequently found in the lung but similar lesions have been reported in extrapulmonary sites such as the genitourinary tract, gastrointestinal tract, the breast, salivary glands, sinonasal tract, orbit, and the central nervous system. Laryngeal involvement of IMT is very rare. The largest case series of eight cases of laryngeal IMT was reported by Wenig et al. in 1995 .
IMT are rare benign tumors. They are also known as plasma cell granuloma. Although benign in nature, they tend to be locally aggressive and it is not uncommon for local invasion and recurrences to occur . Complete excision has been the mainstay of treatment.
Laryngeal IMT has been reported in the pediatric population previously. However, they were mainly isolated cases. We present our unusual case of IMT in a 12-year-old Malay girl who presented to us with hoarseness with no airway issues.
Our patient was a 12-year-old Malay girl from Singapore who presented to our clinic with the complaint of hoarseness for a duration of 9 months after a sore throat. Prior to that she was well. Unlike the typical presentation in recurrent respiratory papillomatosis, when the child tends to present earlier, at the age of 4 or 5 years old, her onset of hoarseness started only when she was 12 years old. It was progressively worsening. Fortunately, she did not have any associated airway issues. She was able to eat and drink normally and there was no suggestion of recent weight loss. The risk factors for hoarseness such as vocal abuse, talking, and singing loudly were also not present in her case. There was no significant family history of note.
A perceptual evaluation of voice quality using GRBAS (Grade, Roughness, Breathiness, Asthenia, and Strain) was performed. She was given a score of G: 3 R: 3 B: 0 A: 3 S: 1.
At that time, our working diagnosis for her included vocal cord polyp, granuloma, and recurrent respiratory papilloma.
The final pathologic analysis suggested the possible diagnosis of IMT.
Histopathology of the biopsy samples (Figs. 3 and 4) revealed myxoid changes and associated atypical-appearing cells characterized by ovoid to spindle-shaped cells with enlarged vesicular to hyperchromatic nuclei but still with an ample amount of eosinophilic to slightly basophilic-appearing cytoplasm, as well as associated multinucleated cells. These features were suggestive of an inflammatory myofibroblastic tumor (IMT).
Immunohistochemical staining showed these cells to have weak reactivity for smooth muscle actin and muscle-specific actin but negative for ALK1, desmin, and S100 protein. A low proliferation rate of less than 5 % was seen by Ki67 staining. CD68 was positive in scattered inflammatory cells but not the atypical cells.
Inflammatory myofibroblastic tumors (IMT) are benign lesions that mimic neoplastic lesions. To date, 39 cases of laryngeal IMT have been described in the English literature. The mean age of disease presentation was 44.5 years with a range of 2 to 74 years old . Coffin et al. reported 84 extrapulmonary cases of IMT in a group of patients ranging from 3 months to 46 years and in this study only three out of the 84 patients had laryngeal IMT and they were all pediatric cases. The larynx is an uncommon site for IMT to occur .
IMT have been previously reported under a variety of names such as plasma cell granuloma, histiocytoma, plasma cell histiocytoma complex, inflammatory fibrosarcoma, and benign myofibroblastoma. However, since 1994, based on the World Health Organization (WHO) guidelines, the terminology inflammatory myofibroblastic tumor (IMT) has been used to describe these lesions . IMT are characterized by myofibroblastic spindle cells on a background of inflammatory cells. Based on Coffin’s classification, it can be divided into three main categories: (1) hypocellular, (2) hypercellular, and (3) collagen sheets pattern. In this first type, the myofibroblasts are organized loosely within a background of inflammatory cells such as plasma cells, lymphocytes, and eosinophils. The second type are densely aggregated, elongated, short spindle cells or stellate cells arranged on a collagenized background, and in the third type, the cellular component is loosely arranged, resembling scar tissue [5–7]. Immunohistochemical staining often plays an important role in the diagnosis of laryngeal IMT. Muscle-specific actin, vimentin, and smooth muscle actin are often present in IMT. Occasionally, desmin and cytokeratins can be stained positive as well .
A child with IMT often presents with similar symptoms as patients with other laryngeal lesions. Hoarseness is the most common complaint. Other symptoms include that of dysphagia, failure to thrive, dyspnea, or stridor. The differential diagnosis to consider in a child who present with hoarseness would include that of recurrent respiratory papillomatosis, vocal cord polyp, and granulomatous lesion . The appearance of IMT on endoscopy has been described as a smooth surface, polypoid or pedunculated lesion, firm and fleshy in nature. The size of which can range from several millimeters to 6 cm [1, 10].
The true causative factor leading to the development of laryngeal IMT remains unknown. Many theories have been proposed and these include trauma, infections, neoplasm, and immunological factors. Smoking has been suggested as a risk factor, as 22.6 % of the patients with laryngeal IMT were smokers. Epstein–Barr virus (EBV) has been shown to be associated with IMT at extralaryngeal sites but not in the larynx [8, 11]. The neoplastic theory has been suggested because of tumor recurrence and malignant progression seen in cases of IMT. Anaplastic lymphoma kinase 1 (ALK 1), chromosomal rearrangement at chromosome 2p23 and p80, have been suggested to be associated with the neoplastic theory .
Laryngeal IMT occurs most commonly in the true vocal cords, followed by the subglottis. Rarely, do they occur in the supraglottis . The presentation complaints vary depending on the site of the lesion. In our case and similar to previous case series, voice change is the most common presentation (74 %), followed by stridor (29 %) and dyspnea, shortness of breath (22.5 %), and globus sensation (16 %).
Prior to surgery, radiological investigations such as computed tomography (CT) scans and magnetic resonance imaging (MRI) are usually performed to determine the extent of the lesion. An MLB with biopsy and immunohistochemical staining of the lesion is often necessary for diagnosis. Surgical excision with good margins is the treatment of choice for this disease. This can be done using an endoscopic technique or an open technique. Endoscopic excision using laser or cold steel instruments is the preferred technique. Open technique is commonly reserved for recurrent cases, cases with poor visualization using endoscope or when malignancy cannot be excluded. We used the endoscopic technique in this case and were able to excise the lesion completely. The advantages of adopting the endoscopic technique were lesser postoperative pain, faster recovery, shorter hospital stay, and better voice outcome. The exposure from the endoscope was adequate for us to visualize the entire lesion and to perform a complete excision. However, as this is our first case, we are still following up this patient closely. At 1 year post surgery, our patient is still disease-free without any recurrence.
Radiotherapy is used mainly to treat local recurrence. The use of chemotherapy is also limited to the treatment of lesion that has undergone malignant transformation or recurrent IMT. Steroid has been used on its own and also as an adjunct with surgery. Steroid as a sole therapy seems to be less effective. However, in a patient with severe comorbidity and surgery carries a high risk, or when the surgery will result in significant function loss, a course of pulsed steroids can be attempted.
The main factors leading to recurrence of disease is often partial/incomplete excision of tumor. The recurrence rate of laryngeal IMT is 8 to 18 % [9, 14]. The recurrence occurs most commonly within 2 to 12 months. In some patients with multiple recurrences, a laryngectomy may have to be considered. We are pleased that our patient has been disease-free throughout the follow-up at the time of submission.
Inflammatory myofibroblastic tumor is an unusual tumor that can mimic a neoplastic process. Many etiologies have been proposed but none has been proven. Immunohistochemical staining plays an important role in the histological diagnosis of IMT. The initial presentation of IMT in a child is most often hoarseness. It is important to exclude laryngeal lesion as a cause of persistent hoarseness in a child. This can be done with the use of a nasoendoscopy. A delay in diagnosis of a laryngeal lesion can result in a life-threatening airway issue. The treatment of choice for IMT remains surgical excision with good margins. The endoscopic approach used in this case results in less postoperative morbidity with no increased recurrence. Good postoperative follow-up is necessary in order to detect any recurrence promptly.
CT, computed tomography; IMT, inflammatory myofibroblastic tumor; MLB, microlaryngobronchoscopy; MRI, magnetic resonance imaging
Dr. Tan Tiong Yong from Changi General Hospital and Dr. Derrick Lian from KK Women’s and Children’s Hospital.
SYT is the first author and is liable for the integrity of the manuscript. AB is the consultant in charge of the abovementioned patient. Both authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Wenig BM, Devaney K, Bisceglia M. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer. 1995;76:2217–29.View ArticlePubMedGoogle Scholar
- Rodrigues M, Taylor RJ, Sun CC, Wolf JS. Inflammatory myofibroblastic tumor of the larynx in a 2-year-old male. ORL J Otorhinolaryngol Relat Spec. 2005;67(2):101–5.View ArticlePubMedGoogle Scholar
- Dava CJ, Hajiioannou JK, Terzis A, Bizakis J. An inflammatory pseudotumour of the larynx: a case report and literature review of an unusual tumour. Ecancermedicalscience. 2012;6:273.PubMedPubMed CentralGoogle Scholar
- Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumour (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.View ArticlePubMedGoogle Scholar
- Ong HS, Ji T, Zhang CP, Li J, Wang LZ, Li RR, et al. Head and neck inflammatory myofibroblastic tumour (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol. 2012;48(2):141–8.View ArticlePubMedGoogle Scholar
- Sul SL, Seol HY, Lee JH, Lee YH, Kim TK, Lee NJ, et al. Inflammatory myofibroblastic tumor of the larynx. Head Neck. 2006;28(4):369–72.View ArticleGoogle Scholar
- Corsi A, Ciofalo A, Leonardi M, Zambetti G, Bosman C. Recurrent inflammatory myofibroblastic tumor of the glottis mimicking malignancy. Am J Otolaryngol. 1997;18(2):121–6.View ArticlePubMedGoogle Scholar
- Idrees MT, Huan Y, Woo P, Wang BY. Inflammatory myofibroblastic tumor of larynx: a benign lesion with variable morphological spectrum. Ann Diagn Pathol. 2007;11(6):433–9.View ArticlePubMedGoogle Scholar
- Kumar S, Gupta AK, Kakkar N. Inflammatory myofibroblastic tumor larynx mimicking laryngeal papillomatosis. Int J Pediatr Otorhinolaryngol Extra. 2009;4:42–4.View ArticleGoogle Scholar
- Ereno C, Lopex JL, Grande J, Santaolalla F, Bilbao FJ. Inflammatory myofibroblastic tumour of the larynx. J Laryngol Otol. 2001;115:856–8.PubMedGoogle Scholar
- Arber DA, Kamel OW, Van de Rijn M, et al. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol. 1995;26:1093–8.View ArticlePubMedGoogle Scholar
- Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569–76.View ArticlePubMedGoogle Scholar
- Alhumaid H, Bukhari M, Rikabi A, Farahat M, Mesallam TA, Malki KH, et al. Laryngeal myofibroblastic tumor: case series and literature review. Int J Health Sci (Qassim). 2011;5:187–95.PubMed CentralGoogle Scholar
- Sautter NB, Krakovitz PR, Kelly ED, et al. Postcricoid inflammatory myofibroblastic tumor (inflammatory pseudotumor) in a 10-year-old girl. Int J Pediatr Otorhinolaryngol Extra. 2006;1:36–40.View ArticleGoogle Scholar